WARTS
Clinical trials for WARTS explained in plain language.
Never miss a new study
Get alerted when new WARTS trials appear
Sign up with your email to follow new studies for WARTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare immune disorder: drug that mobilizes white blood cells enters trial
Disease control Recruiting nowThis study tests whether Mozobil, a drug already used in stem cell transplants, can safely and effectively raise white blood cell counts in people with WHIMS, a rare genetic condition that causes frequent infections. About 20 adults aged 18 to 75 with WHIMS and a history of sever…
Matched conditions: WARTS
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 26, 2026 04:14 UTC
-
New gel could zap away common warts in just weeks
Disease control Recruiting nowThis study tests a medicated gel called YCANTH on common warts caused by HPV. About 300 people aged 2 and older with at least one wart will apply the gel or a fake version. The goal is to see if the gel safely clears all warts by day 84.
Matched conditions: WARTS
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 04:11 UTC
-
New gel shows promise for stubborn warts in extended trial
Disease control Recruiting nowThis study follows people who previously took part in a wart treatment study (COVE-2 or COVE-3) to see if YCANTH gel is safe and works over a longer period. Participants with remaining warts can get up to 4 more treatments, applied every 21 days. The goal is to clear all warts, a…
Matched conditions: WARTS
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New heated patch could zap warts away faster
Disease control Recruiting nowThis study tests whether adding a special microneedle patch (with or without hydrogen peroxide) to heat therapy can better clear viral warts. About 210 people aged 6–65 with common warts will be randomly assigned to one of three groups. The goal is to see which approach leads to …
Matched conditions: WARTS
Phase: NA • Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Scientists track rare immune disease to uncover its secrets
Knowledge-focused Recruiting nowThis study follows people with idiopathic CD4+ lymphocytopenia (ICL), a rare condition where the body has too few CD4+ immune cells, raising the risk of serious infections. Researchers aim to learn how the disease progresses, what causes it, and how it affects the body over time.…
Matched conditions: WARTS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC